Plasmablastic Lymphoma, a Rare Entity in Bone Marrow with Unusual Immunophenotype and Challenging Differential Diagnosis

Plasmablastic lymphoma (PBL) is an aggressive malignancy that usually occurs in the setting of immunosuppression. The immunohistochemical profile of PBL is that of terminally differentiated B lymphocytes. CD138, CD38, and MUM1 are usually immunopositive. However, pan B-cell markers such as CD20 and...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Case Rep Hematol
Auteurs principaux: Al Shaarani, Majd, Shackelford, Rodney E., Master, Samip R., Mills, Glenn M., AlZubaidi, Yasir, Mamilly, Ahmed, Wei, Eric X.
Format: Artigo
Langue:Inglês
Publié: Hindawi 2019
Sujets:
Case Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745100/
https://ncbi.nlm.nih.gov/pubmed/31565447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/1586328
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires